Form 4: Century Therapeutics CEO Sells Shares to Cover Tax Obligations

Century Therapeutics CEO Brent Pfeiffenberger sold 29,552 shares of common stock on May 16, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On May 16, 2025, Brent Pfeiffenberger, the President and CEO of Century Therapeutics, Inc. (IPSC), sold 29,552 shares of common stock.
• The sale was executed at a price of $0.546 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Pfeiffenberger still beneficially owns 1,682,258 shares of Century Therapeutics common stock.

Sentiment

Score: 6

Explanation: The document reports a routine transaction (sale of shares to cover taxes). It's neutral to slightly positive as it reflects compensation being realized.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally not indicative of a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares could have a minor dilutive effect on existing shareholders, but the impact is likely minimal given the relatively small number of shares sold compared to the total outstanding.

Key Dates

Keywords

Century Therapeutics, Brent Pfeiffenberger, IPSC, Form 4, Stock Sale, Tax Obligations, Restricted Stock Units, CEO, Beneficial Ownership